Information Provided By: 
Fly News Breaks for April 12, 2018
HRTX, PCRX
Apr 12, 2018 | 15:01 EDT
Cowen analyst Boris Peaker said a draft bill creating a pass-through payment for non-opioid analgesics as part of surgical procedures appears to exclude Pacira's (PCRX) Exparel, but could benefit Heron Therapeutics' (HRTX) HTX-011. He also noted, though, that several bills would promote the use of local anesthetics. The House E&C committee is planning to move into more formal legislative drafting mode with the goal of reporting legislation out before Memorial Day, Peaker added.
News For PCRX;HRTX From the Last 2 Days
HRTX
Apr 25, 2024 | 10:38 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Biohaven Pharmaceutical... To see the rest of the story go to thefly.com. See Story Here
